Manufacturers Life Insurance Company, The Vaxcyte, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $109 Billion
- Q4 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 158,528 shares of PCVX stock, worth $10.9 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
158,528
Previous 157,024
0.96%
Holding current value
$10.9 Million
Previous $17.9 Million
27.61%
% of portfolio
0.01%
Previous 0.02%
Shares
22 transactions
Others Institutions Holding PCVX
# of Institutions
350Shares Held
130MCall Options Held
539KPut Options Held
253K-
Vanguard Group Inc Valley Forge, PA12MShares$824 Million0.02% of portfolio
-
Janus Henderson Group PLC London, X010.6MShares$729 Million0.46% of portfolio
-
Black Rock Inc. New York, NY9.94MShares$685 Million0.02% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.69MShares$599 Million11.52% of portfolio
-
Capital Research Global Investors Los Angeles, CA6.21MShares$428 Million0.11% of portfolio
About Vaxcyte, Inc.
- Ticker PCVX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,315,100
- Market Cap $4.09B
- Description
- Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...